GNH USA

Europe — EMA

Natterman Bronchicum Extra Sterk (Codeine Phosphate Hemihydrate)

GNH USA supplies Natterman Bronchicum Extra Sterk (Codeine Phosphate), a opioid antitussic for cough suppression. Request a quote for global supply.

Codeine Phosphate Hemihydrate

Request sourcing

1
Pack/s

What is Codeine Phosphate Hemihydrate?

Codeine phosphate, the active ingredient in Natterman Bronchicum Extra Sterk, is an opioid analgesic presented as an oral formulation for oral use. It suppresses cough and may provide mild analgesia in appropriate patients. GNH USA supplies Natterman Bronchicum Extra Sterk as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Codeine Phosphate Hemihydrate used for?

Codeine phosphate acts on the central cough centre and provides opioid analgesia, making it useful for conditions where cough suppression or mild pain relief is needed. - Cough: reduces the frequency and intensity of acute or chronic cough. - Mild to moderate pain: offers short‑term opioid analgesia for transient pain. - Cough associated with respiratory infections: alleviates coughing that accompanies viral or bacterial airway infections.

What are the side effects of Codeine Phosphate Hemihydrate?

Codeine phosphate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or reduced alertness. - Dizziness: sensation of light‑headedness or unsteadiness. - Vomiting: expulsion of stomach contents. - Dry mouth: reduced salivation leading to a parched feeling.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Seizures: convulsive episodes, especially at high doses. - Hypotension: abnormally low blood pressure. - Dependence or addiction: potential for misuse with prolonged use. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

What precautions apply to Codeine Phosphate Hemihydrate?

Before prescribing Natterman Bronchicum Extra Sterk, clinicians should consider several safety factors. - Pregnancy: safety is unknown; use only if the benefit outweighs the risk. - Breastfeeding: unknown safety; assess potential infant exposure. - Renal or hepatic impairment: dose may need adjustment and monitoring. - Concomitant CNS depressants: increased risk of sedation and respiratory depression. - History of substance abuse: avoid due to dependence potential. - Store below 25°C: keep in the original pack, protect from moisture.

What does Codeine Phosphate Hemihydrate interact with?

Codeine phosphate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Other opioid analgesics: additive risk of respiratory depression. - Benzodiazepines: enhanced sedation and respiratory depression. - Alcohol: increased central nervous system depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may raise codeine plasma levels. - CYP3A4 inducers (e.g., rifampicin): may reduce codeine effectiveness. - Anticholinergics: may exacerbate constipation.

Frequently asked questions

What is Natterman Bronchicum Extra Sterk used for?+
Natterman Bronchicum Extra Sterk is a prescription medication containing codeine phosphate, primarily used as a cough suppressant to reduce the frequency and intensity of coughing in patients with acute or chronic cough, and it may also provide short‑term relief of mild to moderate pain when indicated.
How does codeine phosphate work?+
Codeine phosphate is a mu‑opioid receptor agonist. By binding to µ‑receptors in the central nervous system, especially in the medullary cough centre, it raises the threshold for cough reflex activation, thereby suppressing cough. It also exerts mild analgesic effects through the same receptor pathway.
What is the usual dose?+
The specific dose of Natterman Bronchicum Extra Sterk is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and local regulatory guidelines. Patients should follow the prescriber’s instructions and the product label; dosing should not be altered without medical advice.
Is it safe in pregnancy or breastfeeding?+
Safety data for codeine phosphate during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and under close medical supervision.
How do I order Natterman Bronchicum Extra Sterk from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does it compare with other cough suppressants?+
Compared with non‑opioid antitussives such as dextromethorphan, codeine phosphate provides a stronger central cough‑suppressing effect due to its µ‑opioid receptor activity, but it also carries a higher risk of opioid‑related adverse effects and dependence. Selection depends on the severity of cough, patient risk factors and clinical judgment.
What are the storage requirements?+
Natterman Bronchicum Extra Sterk should be stored below 25 °C in a dry place, protected from moisture and direct sunlight. Keep the product in its original packaging until use, and ensure that it is out of reach of children. Do not store in bathrooms or near heat sources.
How is the medication administered?+
The product is intended for oral administration. Patients should swallow the tablet whole with a glass of water, unless the prescribing information advises otherwise. It is usually taken as needed for cough relief, but the exact frequency and timing should follow the prescriber’s directions to avoid excessive dosing.
What are the most serious risks to watch for?+
The most serious risks associated with codeine phosphate include respiratory depression, especially when combined with other central nervous system depressants, severe allergic reactions such as anaphylaxis, and the potential for dependence or abuse. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or uncontrolled cravings.
Who should not use this medication?+
Natterman Bronchicum Extra Sterk should be avoided in individuals with known hypersensitivity to codeine or any component of the formulation, in patients with severe respiratory insufficiency, in those with acute or severe asthma, and in persons with a history of opioid dependence or abuse. Caution is also advised for children, the elderly, and patients with significant hepatic or renal impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Codeine Phosphate Hemihydrate
Route
Oral Use
Manufacturer
Vemedia Manufacturing B. V.
Origin
EU

Related products

Alyostal Prick

Alyostal Prick

Codeine Phosphate Hemihydrate

Stallergenes
EU
Bronchi

Bronchi

Codeine Phosphate Hemihydrate

Cassella-Med Gmbh & Co. Kg
EU
Bronchodine

Bronchodine

Codeine Phosphate Hemihydrate

Laboratoires Sterop
EU
Codant

Codant

Codeine Phosphate Hemihydrate

Mercury Pharmaceuticals (Ireland) Ltd.
EU